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n Specific proteins are required to
translocate phosphatidylcholine
bidirectionally across the
endoplasmic reticulum.
Anant K Menon, William E Watkins
III and Sigrún Hrafnsdóttir (2000).
Curr. Biol. 10, 241–252.
A long-standing problem in
understanding the mechanism by which
the phospholipid bilayer of biological
membranes is assembled concerns how
phospholipids flip back and forth
between the two leaflets of the bilayer.
This question is important because
phospholipid biosynthetic enzymes
typically face the cytosol and deposit
newly synthesized phospholipids in the
cytosolic leaflet of biogenic membranes
such as the endoplasmic reticulum
(ER). These lipids must be transported
across the bilayer to populate the
exoplasmic leaflet for membrane
growth. Transport does not occur
spontaneously and it is presumed that
specific membrane proteins—flippases
—are responsible for phospholipid flip-
flop. No biogenic membrane flippases
have been identified. To test the
hypothesis that specific proteins
facilitate phospholipid flip-flop in the
ER, the authors reconstituted transport-
active proteoliposomes from detergent-
solubilized ER vesicles under
conditions in which protein-free
liposomes containing ER lipids were
inactive. Transport measurements and
chromatographic analyses showed that
specific proteins are required to
translocate a phosphatidylcholine
analogue across the ER membrane.
These proteins are likely to be the
flippases, which are required to
translocate natural phosphatidylcholine
and other phospholipids across the ER
membrane. 
21 February 2000, Research Paper,
Current Biology. 
n Microarray analysis of the
transcriptional network
controlled by the photoreceptor
homeobox gene Crx.
FJ Livesey, T Furukawa, MA Steffen,
GM Church and CL Cepko (2000).
Curr. Biol. 10, 301–310.
Terminal differentiation of many cell
types is controlled and maintained by
tissue- or cell-specific transcription
factors. Little is known, however, about
the transcriptional networks controlled
by such factors and how they regulate
differentiation. The paired-type
homeobox transcription factor Crx has a
pivotal role in the terminal
differentiation of vertebrate
photoreceptors. Mutations in the human
CRX gene result in either congenital
blindness or photoreceptor degeneration
and targeted mutation of the mouse Crx
results in failure of development of the
light-detecting outer segment of
photoreceptors. The authors have
characterized the transcriptional
network controlled by Crx by microarray
analysis of gene expression in
developing retinal tissue from Crx+/+ and
Crx–/– mice. These data were combined
with analyses of gene expression in
developing and adult retina, as well as
adult brain. The most abundant
elements of this network are ten
photoreceptor-specific or -enriched
genes, including six phototransduction
genes. The study shows that cDNA
microarrays can be used to define the
transcriptional networks controlled by
transcription factors in vertebrate tissue
in vivo. 
6 March 2000, Research Paper, Current
Biology. 
n Phosphatidylinositol
4,5-bisphosphate induces
actin-based movement of
raft-enriched vesicles through
WASP–Arp2/3.
AL Rozelle, LM Machesky,
M Yamamoto, MHE Driessens,
RH Insall, MG Roth, K Luby-Phelps,
G Marriott, A Hall and HL Yin
(2000). Curr. Biol. 10, 311–320.
Phosphatidylinositol 4,5-bisphosphate
(PIP2) has been implicated in the
regulation of the actin cytoskeleton and
vesicle trafficking. It stimulates de novo
actin polymerization by activating the
pathway involving the Wiskott–Aldrich
syndrome protein (WASP) and the actin-
related protein complex Arp2/3. Actin
polymerizes from cholesterol–
sphingolipid-rich membrane
microdomains called ‘rafts’, in a manner
dependent on tyrosine phosphorylation.
Although actin has been implicated in
vesicle trafficking, and rafts are sites of
active phosphoinositide and tyrosine
kinase signaling that mediate apically
directed vesicle trafficking, it is not
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known whether phosphoinositide
regulation of actin dynamics occurs in
rafts, or if it is linked to vesicle
movements. The authors show that
sphingolipid–cholesterol rafts are
preferred platforms for membrane-
linked actin polymerization. This is
mediated by in situ PIP2 synthesis and
tyrosine kinase signaling through the
WASP–Arp2/3 pathway. Actin comets
may provide a novel mechanism for raft-
dependent vesicle transport and apical
membrane trafficking. 
7 March 2000, Research Paper, Current
Biology. 
n LICOS, a primordial
costimulatory ligand?
D Brodie, AV Collins, A Iaboni,
JA Fennelly, LM Sparks, X-N Xu,
PA van der Merwe and SJ Davis
(2000). Curr. Biol. 10, 333–336.
In mammals, the classical B7 molecules
expressed on antigen-presenting cells,
B7-1 (CD80) and B7-2 (CD86), bind the
structurally related glycoproteins CD28
and CTLA-4 (CD152), generating
costimulatory signals that regulate the
activation state of T cells. A recently
identified human CD28-like protein,
ICOS, also induces costimulatory signals
in T cells when cross-linked with
antibodies, but it is unclear whether
ICOS is part of a B7-mediated regulatory
pathway of previously unsuspected
complexity, or whether it functions
independently and in parallel. The
authors report that, rather than binding
B7-1 or B7-2, ICOS binds a new B7-
related molecule of previously unknown
function that they call LICOS. The
results define the components of a
distinct and novel costimulatory pathway
and also raise the possibility that
LICOS, rather than B7-1 or B7-2, is the
contemporary homologue of a primordial
vertebrate costimulatory ligand.
10 March 2000, Brief Communication,
Current Biology. 
n G-protein-coupled receptors
function as oligomers in vivo.
Mark C Overton and Kendall J
Blumer (2000). Curr. Biol. 10,
341–344.
Hormones, sensory stimuli,
neurotransmitters and chemokines
signal by activating G-protein-coupled
receptors (GPCRs). Although GPCRs
are thought to function as monomers,
they can form dimers, and coexpression
of two nonfunctional or related GPCRs
can result in rescue of activity or
modification of function. Dimerization
of peptides corresponding to the third
cytoplasmic loops of GPCRs increases
their potency as activators of G proteins
in vitro, and peptide inhibitors of
dimerization diminish β2-adrenergic
receptor signaling. It is not known
whether GPCRs exist as monomers or
oligomers in intact cells and
membranes, whether agonist binding
regulates monomer–oligomer
equilibrium, or whether oligomerization
governs GPCR function. The authors
report that the α-factor receptor, a
GPCR that is the product of the STE2
gene in the yeast Saccharomyces cerevisiae,
is oligomeric in intact cells and
membranes. They suggest that
oligomerization is likely to govern
GPCR signaling and regulation.
10 March 2000, Brief Communication,
Current Biology. 
n NMR structure of an anti-gp120
antibody complex with a V3
peptide reveals a surface
important for co-receptor
binding.
Vitali Tugarinov, Anat Zvi, Rina Levy,
Yehezkiel Hayek, Shuzo Matsushita
and Jacob Anglister (2000).
Structure 8, 385–396.
The envelope glycoprotein of human
immunodeficiency virus type-1 (HIV-1),
which consists of an external domain,
gp120, and a transmembrane domain,
gp41, is the most important target for
the humoral immune response that is
elicited by an anti-HIV vaccine. The
protein 0.5β is a potent strain-specific
HIV-1 neutralizing antibody raised
against the entire gp120 of the HIV-1IIIB
strain. The epitope recognized by 0.5β
is located within the third hypervariable
region (V3) of gp120. Recently, several
HIV-1 V3 residues involved in co-
receptor utilization and selection were
identified. The nuclear magnetic
resonance (NMR) results presented in
this paper suggest that the surface of the
V3 peptide in contact with the antibody
is likely to correspond to a solvent-
exposed region in the native gp120
molecule. The conformation of the
V3IIIB peptide bound to 0.5 consists of
two antiparallel  strands linked by a
QRGPGR loop (single-letter amino acid
code). The structure of the binding site
of the anti-gp120 antibody in complex
with the V3 peptide can be used to
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analyze the structural and functional
implications of sequence variations on
co-receptor usage and antibody
specificity. This structure might help to
construct a cocktail of V3 peptides that
will induce a broadly neutralizing
immune response. In the absence of the
three-dimensional structure of the
chemokine receptor involved in HIV-1
infection, the structure of V3 might be
useful to design anti-HIV-1 drugs that
target this receptor.
24 March 2000 Research Paper,
Structure. 
n Solution structure of PCP, a
prototype for the peptidyl carrier
domains of modular peptide
synthetases.
Thomas Weber, Roland
Baumgartner, Christian Renner,
Mohamed A Marahiel and Tad
A Holak (2000). Structure 8,
407–418.
Nonribosomal peptide synthetases
(NRPSs) are large modular enzymes
responsible for the synthesis of a variety
of microbial bioactive peptides. They
consist of modules and each one
recognises and incorporates one specific
amino acid into the peptide product. A
module comprises several domains,
which carry out the individual reaction
steps. After activation by the
adenylation domain, the amino acid
substrate is covalently tethered to a
4′-phosphopantetheinyl cofactor of a
peptidyl carrier domain (PCP) that
passes the substrate to the reaction
centres of the consecutive domains. The
solution structure of PCP, a distinct
peptidyl carrier protein derived from the
equivalent domain of an NRPS, was
solved using NMR techniques. PCP is a
distorted four-helix bundle with an
extended loop between the first two
helices. Its overall fold resembles the
topology of acyl carrier proteins (ACPs)
from Escherichia coli fatty acid synthase
and actinorhodin polyketide synthase
from Streptomyces coelicolor, but the
surface polarity and the length and
relative alignment of the helices are
different. The conserved serine — the
cofactor-binding site — is situated
within a stretch of seven flexible
residues. The structure of PCP reflects
its character as a protein domain. The
flexibility of the post-translationally
modified site might have implications
for interactions with the cooperating
proteins or NRPS domains.
29 March 2000, Research Paper,
Structure. 
n NF-κB p65 (RelA) homodimer
uses distinct mechanisms to
recognize DNA targets.
Yong-Qing Chen, Lei Lei
Sengchanthalangsy, Arthur Hackett
and Gourisankar Ghosh (2000).
Structure 8, 419–428.
The NF-κB family of dimeric
transcription factors regulates the
expression of several genes by binding
to a variety of related DNA sequences.
One of these dimers, p65(RelA),
regulates a subclass of these targets. p65
binds to the 5′-GGAA T TTTC-3′
sequence asymmetrically. In that
complex, one subunit base specifically
interacts with the preferred 5′ half site
and the other subunit binds
nonspecifically to the 3′ half site. The
crystal structures of two new p65–DNA
complexes are described in this paper.
The structures reveal that p65 exhibits
the unique capability to specifically
bind DNA targets of variable lengths
from four to ten base pairs. Also, the
small protein segment Arg41–Ser42–
Ala43 is at least partially responsible for
flexibility in DNA-binding modes. 
30 March 2000, Research Paper,
Structure. 
n The 1.8 Å crystal structure of
catechol 1,2-dioxygenase reveals
a novel hydrophobic helical
zipper as a subunit linker.
Matthew W Vetting and Douglas H
Ohlendorf (2000). Structure 8,
429–440.
Intradiol dioxygenases catalyze the
critical ring-cleavage step in the
conversion of catecholate derivatives to
citric acid cycle intermediates. Catechol
1,2-dioxygenases (1,2-CTDs) have a
rudimentary design structure — a
homodimer with one catalytic non-heme
ferric ion per monomer, that is (αFe3+)2.
This is in contrast to the archetypical
intradiol dioxygenase protocatechuate
3,4-dioxygenase (3,4-PCD), which forms
more diverse oligomers, such as
(αβFe3+)2–12. The crystal structure of
1,2-CTD from Acinetobacter sp. ADP1
(Ac 1,2-CTD) was solved and the
structures of the enzyme complexed
with catechol and 4-methylcatechol
were also determined. Although the
characteristics of the iron ligands are
similar, Ac 1,2-CTD differs from
3,4-PCDs in that only one subunit is
used to fashion each active-site cavity.
In addition, a novel ‘helical zipper’,
consisting of five amino-terminal helices
from each subunit, forms the molecular
dimer axis. Two phospholipids were
unexpectedly found to bind within a
hydrophobic tunnel along this axis. The
helical zipper domain of Ac 1,2-CTD
has no equivalent in other proteins of
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known structure. Sequence analysis
suggests the domain is a common motif
in all members of the 1,2-CTD family.
The structures presented in this paper
are the first of a new family of intradiol
dioxygenases.
30 March 2000 Research Paper,
Structure. 
n A high-resolution structure of a
DNA–chromomycin–Co(II)
complex determined from
pseudocontact shifts in nuclear
magnetic resonance.
Miriam Gochin (2000). Structure 8,
441–452.
The drug chromomycin-A3 binds to the
minor groove of DNA and requires a
divalent metal ion for complex
formation. 1H, 31P and 13C
pseudocontact shifts occurring in the
presence of a tightly bound divalent
cobalt ion in the complex between
d(TTGGCCAA)2 and chromomycin-A3
have been used to determine the
structure of the complex. The accuracy
of the structure was verified by
validation with nuclear Overhauser
enhancements (NOEs) and J-coupling
constants not used in the structure
calculation. The structure was compared
with a structure obtained in an earlier
study using NOEs to assess the accuracy
of NOEs in giving global structural
information for a DNA complex.
Although some basic features of the
structures agreed, they differed
substantially in the fine structural
details and in the DNA axis curvature
generated by the drug. The distortion of
base-pair planarity that was observed in
the NOE structure was not seen in the
structure determined in this paper.
Differences in drug orientation and
hydrogen bonding also occurred. The
curvature and elongation of the DNA
that was obtained previously was not
found to occur. The use of
pseudocontact shifts has enabled the
authors to obtain a high-precision global
structure of the chromomycin–DNA
complex, which provides an accurate
template on which to consider targeting
minor groove binding drugs. The effect
of such binding is not propagated far
along the helix but is restricted to a local
kink in the axis that reverts to its
original direction within four base pairs.
30 March 2000, Research Paper,
Structure. 
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